The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design

被引：90
|
作者：
Scarf, Alana M. [1 ,2 ]
Ittner, Lars M. [1 ,3 ]
Kassiou, Michael [1 ,4 ,5 ]
机构：
[1] Brain & Mind Res Inst, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia
[4] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
[5] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 03期
关键词：
PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; POSITRON-EMISSION-TOMOGRAPHY; ADENINE-NUCLEOTIDE CARRIER; DEPENDENT ANION CHANNEL; RAT SCIATIC-NERVE; CELLS IN-VITRO; MICROGLIAL ACTIVATION;
D O I：
10.1021/jm8011678
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：581 / 592
页数：12
相关论文
共 50 条
  • [41] Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients
    Harberts, Erin
    Datta, Dibyadeep
    Chen, Selby
    Wohler, Jillian E.
    Oh, Unsong
    Jacobson, Steven
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (01) : 51 - 57
  • [42] A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)
    Piccinonna, Sara
    Margiotta, Nicola
    Denora, Nunzio
    Iacobazzi, Rosa Maria
    Pacifico, Concetta
    Trapani, Giuseppe
    Natile, Giovanni
    DALTON TRANSACTIONS, 2013, 42 (28) : 10112 - 10115
  • [43] Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma
    Papadopoulos, Vassilios
    Lecanu, Laurent
    EXPERIMENTAL NEUROLOGY, 2009, 219 (01) : 53 - 57
  • [44] Design, Synthesis, and Biological Evaluation of Novel Fluorescent Probes Targeting the 18-kDa Translocator Protein
    Wongso, Hendris
    Yamasaki, Tomoteru
    Kumata, Katsushi
    Ono, Maiko
    Higuchi, Makoto
    Zhang, Ming-Rong
    Fulham, Michael J.
    Katsifis, Andrew
    Keller, Paul A.
    CHEMMEDCHEM, 2021, 16 (12) : 1902 - 1916
  • [45] Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
    Veenman, Leo
    Gavish, Moshe
    Kugler, Wilfried
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (04) : 559 - 577
  • [46] The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned?
    Luus, Christopher
    Hanani, Raphy
    Reynolds, Aaron
    Kassiou, Michael
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (7-8) : 501 - 510
  • [47] Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile
    Nothdurfter, C.
    Rammes, G.
    Baghai, T. C.
    Schuele, C.
    Schumacher, M.
    Papadopoulos, V.
    Rupprecht, R.
    JOURNAL OF NEUROENDOCRINOLOGY, 2012, 24 (01) : 82 - 92
  • [48] Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization
    Taliani, Sabrina
    Da Pozzo, Eleonora
    Bellandi, Marusca
    Bendinelli, Sara
    Pugliesi, Isabella
    Simorini, Francesca
    La Motta, Concettina
    Salerno, Silvia
    Marini, Anna Maria
    Da Settimo, Federico
    Cosimelli, Barbara
    Greco, Giovanni
    Novellino, Ettore
    Martini, Claudia
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (10) : 4085 - 4093
  • [49] Whole Body Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, [18F]-FEPPA, to Image Translocator Protein (18 kDa)
    Mizrahi, Romina
    Rusjan, Pablo M.
    Vitcu, Irina
    Ng, Alvina
    Wilson, Alan A.
    Houle, Sylvain
    Bloomfield, Peter M.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (03) : 353 - 359
  • [50] Developmental Expression of the Translocator Protein 18 kDa (TSPO) in Testicular Germ Cells
    Manku, G.
    Wang, Y.
    Thuillier, R.
    Rhodes, C.
    Culty, M.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (04) : 467 - 475
12345